Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Susceptibility of Lung Cancer with Polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 Genotypes in the Population of Inner Mongolia Region

  • Jiang, Xue-Yan (School of Pharmacy, Inner Mongolia Medical University) ;
  • Chang, Fu-Hou (School of Pharmacy, Inner Mongolia Medical University) ;
  • Bai, Tu-Ya (School of Pharmacy, Inner Mongolia Medical University) ;
  • Lv, Xiao-Li (School of Pharmacy, Inner Mongolia Medical University) ;
  • Wang, Min-Jie (School of Pharmacy, Inner Mongolia Medical University) ;
  • Wang, Guang (The First Affiliated Hospital, Inner Mongolia Medical University)
  • Published : 2014.07.15
Download PDF
⟨ Previous Next ⟩

Abstract

Background: To study the relationship of susceptibility to lung cancer with the gene polymorphisms of CYP1A1, GSTM1, GSTM3, GSTT1, GSTP1 and smoking status in Han and Mongolian populations of Inner Mongolia, an autonomous region of China. Materials and Methods: PCR-RFLP, allele-specific and multiplex PCR were employed to identify the genotypes of CYP1A1, GSTM1, GSTM3, GSTT1 and GSTP1 in a case-control study of 322 lung cancer patients diagnosed by bronchoscopy and 456 controls free of malignancy. Results: There is a significant difference in genotypic frequency of GSTT1 of healthy Mongolian and Han subjects. A statistically prominent association was found between CYP1A1 Msp1 (vt/vt) (OR=4.055, 95%CI:2.107-7.578, p=0.000), GSTM1 (-) (OR=2.290, 95%CI:1.467-3.573, p=0.000) and lung cancer in Mongolians. Similarly, in the Han population, CYP1A1 Msp1 (vt/vt) (OR=3.194, 95%CI:1.893-5.390, p=0.000) and GSTM1 (-) (OR=1.884, 95%CI:1.284-2.762, p=0.001) carriers also had an elevated risk of lung cancer. The smokers were more susceptible to lung cancer 2.144 fold and 1.631 fold than non-smokers in Mongolian and Han populations, respectively. The smokers who carried with CYP1A1 Msp1 (wt/vt+vt/vt), exon7 (Val/Val+Ile /Val), GSTM1 (-), GSTM3 (AB+BB), and GSTT1 (-) respectively were found all to have a high risk of lung cancer. Conclusions: CYP1A1 Msp1 (vt/vt) and GSTM1 (-) are risk factors of lung cancer in Han and Mongolian population in the Inner Mongolia region. The smokers with CYP1A1 Msp1 (wt/vt+vt/vt), CYP1A1 exon7 (Val/Val+Ile /Val), GSTM1 (-), GSTM3 (AB+BB), and GSTT1 (-) genotypes, respectively, are at elevated risk of lung cancer.

Keywords

References

  1. Bai TY, Chang FH, Wang MJ, et al (2011). Relationship between GSTT1 and CYP1A1 genetic polymorphisms and lung cancer susceptibility. Chinese J Public Health, 27, 723-5.
  2. Benhamou S, Lee WJ, Alexandrie AK, et al (2002). Meta- and pooled analyses of the effects of glutathione S-transferase M1 polymorphisms and smoking on lung cancer risk. Carcinogenesis, 23, 1343-50. https://doi.org/10.1093/carcin/23.8.1343
  3. Chang FH, Hu TM (2006). Polymorphisms of CYP1A1 gene MspI site in the Mongolian and Han nationality populations of Inner Mongolia of China. Zhonghua Yi Xue Yi Chuan Xue Za Zhi, 23, 333-4.
  4. Chan-Yeung M, Tan-Un KC, Ip MS, et al (2004). Lung cancer susceptibility and polymorphisms of glutathione-S-transferase genes in Hong Kong. Lung Cancer, 45, 155-60. https://doi.org/10.1016/j.lungcan.2004.01.016
  5. Chen S, Xuek, XU L, Ma G, et al (2001). Polymorphisms of the CYP1A1 and GSTM1 genes in relation to individual susceptibility to lung carcinoma in Chinese population. Mutat Res, 458, 41-7.
  6. Chow HH, Garland LL, Hsu CH, et al (2010). Resveratrol modulates drug-and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev Res, 3, 1168-75. https://doi.org/10.1158/1940-6207.CAPR-09-0155
  7. Danie P. K. Ng, Kar-Wai Tan, Bin Zhao, et al (2005). CYP1A1 polymorphisms and risk of lung cancer in non-smoking Chinese women: influence of environmental tobacco smoke exposure and GSTM1/T1genetic variation. Cancer Causes Control, 16, 399-405. https://doi.org/10.1007/s10552-004-5476-0
  8. Guan P, Huang D, Yin Z, et al (2011). Association of the hOGG1 Ser326Cys polymorphism with increased lung cancer susceptibility in Asians: a meta-analysis of 18 studies including 7592 cases and 8129 controls. Asian Pac J Cancer Prev, 12, 1067-72.
  9. Hayashi SI, Watanabe J, Nakachi K, et al (1991). PCR detection of an A/G polymorphism within exon7 of the CYP1A1 gene. Nucleic Acids Research, 19, 4797.
  10. Hayashi SI, Watanabe J, Nakachi K, et al (1991). Genetic linkage of lung cancer-associated Msp1 polymorphisms with amino acid replacement in the heme binding region of human cytochrome P4501A1 gene. J Biochem, 110, 407-11. https://doi.org/10.1093/oxfordjournals.jbchem.a123594
  11. Hayes JD, Flanagan JU, Jowsey IR (2005). Glutathione transferases. Annu Rev Pharmacol Toxtcol, 45, 51-88. https://doi.org/10.1146/annurev.pharmtox.45.120403.095857
  12. Hecht SS, Carmella SG, Yoder A, et al (2006). Comparison of polymorphisms in genes involved in polycyclic aromatic hydrocarbon metabolism with urinary phenanthrene metabolite ratios in smokers. Cancer Epidemiol Biomarkers Prev, 15, 1805-11. https://doi.org/10.1158/1055-9965.EPI-06-0173
  13. Houlston RS (1999). Glutathione S-transferase M1 status and lung cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev, 8, 675-82.
  14. Ihsan R, Chauhan PS, Mishra AK, et al (2011). Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non smokers in lung cancer. PLoS one, 6, 29431 https://doi.org/10.1371/journal.pone.0029431
  15. Inskip A, Elexperu CJ, Buxton N, et al (1995). Identification of polymorphism at the glutathione S-transferase, GSTM3 locus: evidence for linkage with GSTM1*A. Biochem J, 3, 713-6.
  16. Jin-Mei Piao, Min-Ho Shin, Hee Nam Kim, et al (2010). Glutathione-S-transferase (GSTM1, GSTT1) null phenotypes and risk of lung cancer in a Korean population. Asian Pac J Cancer Prev, 14, 7165-9. https://doi.org/10.7314/APJCP.2013.14.12.7165
  17. Jin Y, Xu H, Zhang C, et al (2010). Combined effects of cigarette smoking, gene polymorphisms and methylations of tumor suppressor genes on non small cell lung cancer: a hospital based case-control study in China. BMC Cancer, 10, 422. https://doi.org/10.1186/1471-2407-10-422
  18. Kawajiri K, Nakachi K, Imai K, et al (1990). Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450IA1 gene. FEBS, 263, 131-3. https://doi.org/10.1016/0014-5793(90)80721-T
  19. Kim SJ1, Kim MG, Kim KS, et al (2008). Impact of glutathione S-transferase M1 and T1 gene polymorphisms on the smoking-related coronary artery disease\. J Korean Med Sci, 3, 365-72.
  20. Le Marchand L, Sivaraman L, Pierce L, et al (1998). Association of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Res, 58, 4858-63.
  21. Liu F, He Y, Peng X, et al (2010). Association of the 8473T>C cyclooxygenase-2 (COX-2) gene polymorphism with lung cancer risk in Asians. Asian Pac J Cancer Prev, 11, 1257-62.
  22. London SJ, Yuan JM, Coetzee GA, et al (2000). CYP1A1 I462V genetic polymorphism and lung cancer risk in a cohort of men in Shanghai, China. Cancer Epidemiol, Biomarkers Prev, 9, 987-91.
  23. Malik MA, Upadhyay R, Mittal RD, et al (2010). Association of xenobiotic metabolizing enzymes genetic polymorphisms with esophageal cancer in Kashmir Valley and influence of environmental factors. Nutr Cancer, 62, 734-42. https://doi.org/10.1080/01635581003605904
  24. Mcllwain CC, TownsendDM, Tew KD (2006). Glutathione S-transferase polymorphisms:cancer incidence and therapy. Oncogene, 25, 1639-48. https://doi.org/10.1038/sj.onc.1209373
  25. NorppaH (2004). Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett, 149, 309-34. https://doi.org/10.1016/j.toxlet.2003.12.042
  26. Pearson WR, Vorachek WR, Xu SJ, et al (1993). Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13. Am J Hum Genet, 1, 220-33.
  27. Shaffi SM1, Shah MA, Bhat IA, et al (2009). CYP1A1 polymorphisms and risk of lung cancer in the ethnic kashmiri population. Asian Pac J Cancer Prev, 10, 651-6
  28. Shou M, Krausz KW, Gonzalez FJ, et al (1996). Metabolic activation of the potent carcinogen dibenzo (a, 1) pyrene by human recombinant CYP450, lung and liver microsomes.Carcinogenesis, 17, 2429-33. https://doi.org/10.1093/carcin/17.11.2429
  29. Shimada T, Hayes CL, Yamazaki H, et al (1996). Activation of chemically diverse procarcinogens by human cytochrome P4501B1. Cancer Res, 56, 2979-84.
  30. Shin A, Kim J (2010). Effect modification of meat intake by genetic polymorphisms on colorectal neoplasia susceptibility. Asian Pac J Cancer Prev, 11, 281-7.
  31. Sobti RC, Sharma S, Joshi A, et al (2004). Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population. Molec Cellular Biochem, 226, 1-9.
  32. Song N, Tan W, Xing D, et al (2001). CYP1A1 polymorphism and risk to lung cancer in relation to tobacco smoking: A case-control study in China. Carcinogenesis, 22, 11-6. https://doi.org/10.1093/carcin/22.1.11
  33. Shukla R, Tilak A, Kumar C, et al (2013). Associations of CYP1A1, GSTM1 and GSTT1 polymorphisms with lung cancer susceptibility in a northern indian population. Asian Pac J Cancer Prev, 14, 3345-9. https://doi.org/10.7314/APJCP.2013.14.5.3345
  34. Shi XQ, Zhou SH, Wang ZG, et al (2008). CYP1A1 and GSTM1 polymorphisms and lung cancer risk in Chinese populations: A meta-analysis. Lung Cancer, 59, 155-63. https://doi.org/10.1016/j.lungcan.2007.08.004
  35. Singh AP, Pant MC, Ruwali M, et al (2010). Polymorphism in cytochrome P450 1A2 and their interaction with risk factors in determing risk of squamous cell lung carcinoma in men. Cancer Biomark, 8, 351-9.
  36. Veglia F, Vineis P, Overvad K, et al (2007). Occupational exposures, environmental tobacco smoke, and lung cancer. Epidemiology, 18, 769-75. https://doi.org/10.1097/EDE.0b013e318142c8a1

Cited by

  1. Evaluation of Risk Factors for Nasopharyngeal Carcinoma in a High-risk Area of India, the Northeastern Region vol.16, pp.12, 2015, https://doi.org/10.7314/APJCP.2015.16.12.4927
  2. Influence of the CYP1A1 T3801C Polymorphism on Tobacco and Alcohol-Associated Head and Neck Cancer Susceptibility in Northeast India vol.16, pp.16, 2015, https://doi.org/10.7314/APJCP.2015.16.16.6953
  3. CYP1A1 and GSTP1 gene variations in breast cancer: a systematic review and case–control study vol.15, pp.2, 2016, https://doi.org/10.1007/s10689-015-9849-1
  4. CYP1A1 MspI Polymorphism and Cervical Carcinoma Risk in the Multi-Ethnic Population of Malaysia: a Case-Control Study vol.17, pp.1, 2016, https://doi.org/10.7314/APJCP.2016.17.1.57
  5. The interaction between smoking and CYP1A1 MspI polymorphism on lung cancer: a meta-analysis in the Chinese population vol.26, pp.5, 2016, https://doi.org/10.1111/ecc.12459
  6. Synergistic Association of CYP1A1 Polymorphisms with Increased Susceptibility to Squamous Cell Lung Cancer in North Indian Smokers vol.31, pp.4, 2016, https://doi.org/10.5301/jbm.5000221